Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International Inc (BKYI) delivers innovative biometric authentication solutions for enterprise security and identity management. This dedicated news hub provides investors and industry professionals with complete access to official company announcements and verified developments.
Track all critical updates including earnings disclosures, product launches, strategic partnerships, and regulatory filings. Our curated collection ensures efficient monitoring of BKYI's advancements in fingerprint biometrics, identity-as-a-service platforms, and cybersecurity innovations.
Discover updates on key operational areas: deployment of PortalGuard® identity solutions, government sector contracts, and advancements in passwordless authentication technology. Content is rigorously verified to support informed decision-making in the biometrics and cybersecurity markets.
Bookmark this page for streamlined access to BIO-key's latest milestones. Check regularly for authoritative updates on one of the biometric industry's most dynamic providers of hardware and software authentication solutions.
BIO-key International (Nasdaq: BKYI) announced receiving a Notification Letter from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1), due to the failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The company filed a Notification of Late Filing on March 31, 2023, citing the need for more time to compile necessary financial information. The Notification Letter allows the company 60 days to submit a plan for compliance, potentially extending the deadline to October 16, 2023. The company's common stock remains listed on the Nasdaq Capital Market. BIO-key emphasizes its commitment to filing the Form 10-K as soon as possible to regain compliance.